Results from the BELIEVE trial showed that after 72 weeks, participants receiving the combination therapy experienced an average weight reduction of 22.1% , significantly outperforming Bimagrumab alone (10.8%) and semaglutide alone (15.7%)
Check with your doctor immediately if any of the following side effects occur: More common Diarrhea stomach pain Less common Difficulty in breathing or swallowing fast heartbeat gaseous stomach pain heartburn recurrent fever skin itching, rash, or redness stomach fullness swelling of the face, throat, or tongue vomiting yellow eyes or skin Incidence not known Anxiety bloating blurred vision change in vision changes in behavior chest tightness chills cold sweats coma confusion constipation cool, pale skin cough darkened urine depression dizziness dry mouth fast heartbeat fever increased hunger indigestion large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs loss of appetite nausea nervousness nightmares pains in the stomach, side, or abdomen, possibly radiating to the back puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue seizures shakiness slurred speech sunken eyes thoughts of harming oneself unusual tiredness or weakness wrinkled skin Some side effects may occur that usually do not need medical attention
Start your intake What Is Zepbound and How Does It Differ from Tirzepatide
Tirzepatide follows a similar chronic treatment model to semaglutide
